1421503-38-9 | 4-Bromo-5-ethyl-2-fluorophenol

1421503-38-9    1421503-40-3 

[1]CurrentPatentAssignee:PFIZERINC-WO2013/14567,2013,A1

[2]Jones,Peter;Storer,R.Ian;Sabnis,YogeshA.;Wakenhut,FlorianM.;Whitlock,GavinA.;England,KatherineS.;Mukaiyama,Takasuke;Dehnhardt,ChristophM.;Coe,JothamW.;Kortum,SteveW.;Chrencik,JillE.;Brown,DavidG.;Jones,RhysM.;Murphy,JohnR.;Yeoh,Thean;Morgan,Paul;Kilty,Iain[JournalofMedicinalChemistry,2017,vol.60,#2,p.767-786]

[3]CurrentPatentAssignee:HENANMEDINNOPHARMACEUTICALTECH;HENANMEDINNOPHARMACEUTICALTECHNOLOGY-CN111606908,2020,A

[4]Wellaway,ChristopherR.;Baldwin,IanR.;Bamborough,Paul;Barker,Daniel;Bartholomew,MichelleA.;Chung,Chun-Wa;Dümpelfeld,Birgit;Evans,JohnP.;Fazakerley,NealJ.;Homes,Paul;Keeling,StevenP.;Lewell,XiaoQ.;McNab,FinlayW.;Morley,Joanne;Needham,Deborah;Neu,Margarete;VanOosterhout,AntoonJ.M.;Pal,Anshu;Reinhard,FriedrichB.M.;Rianjongdee,Francesco;Robertson,CraigM.;Rowland,Paul;Shah,RishiR.;Sherriff,EmmaB.;Sloan,LisaA.;Teague,Simon;Thomas,DanielA.;Wellaway,Natalie;Wojno-Picon,Justyna;Woolven,JamesM.;Coe,DianeM.[JournalofMedicinalChemistry,2022,vol.65,#1,p.633-664]

1421503-38-9    76513-69-4    1421503-39-0 

[1]CurrentPatentAssignee:PFIZERINC-WO2013/14567,2013,A1Locationinpatent:Page/Pagecolumn65

[2]Jones,Peter;Storer,R.Ian;Sabnis,YogeshA.;Wakenhut,FlorianM.;Whitlock,GavinA.;England,KatherineS.;Mukaiyama,Takasuke;Dehnhardt,ChristophM.;Coe,JothamW.;Kortum,SteveW.;Chrencik,JillE.;Brown,DavidG.;Jones,RhysM.;Murphy,JohnR.;Yeoh,Thean;Morgan,Paul;Kilty,Iain[JournalofMedicinalChemistry,2017,vol.60,#2,p.767-786]

[3]Wellaway,ChristopherR.;Baldwin,IanR.;Bamborough,Paul;Barker,Daniel;Bartholomew,MichelleA.;Chung,Chun-Wa;Dümpelfeld,Birgit;Evans,JohnP.;Fazakerley,NealJ.;Homes,Paul;Keeling,StevenP.;Lewell,XiaoQ.;McNab,FinlayW.;Morley,Joanne;Needham,Deborah;Neu,Margarete;VanOosterhout,AntoonJ.M.;Pal,Anshu;Reinhard,FriedrichB.M.;Rianjongdee,Francesco;Robertson,CraigM.;Rowland,Paul;Shah,RishiR.;Sherriff,EmmaB.;Sloan,LisaA.;Teague,Simon;Thomas,DanielA.;Wellaway,Natalie;Wojno-Picon,Justyna;Woolven,JamesM.;Coe,DianeM.[JournalofMedicinalChemistry,2022,vol.65,#1,p.633-664]

[4]CurrentPatentAssignee:HENANMEDINNOPHARMACEUTICALTECH;HENANMEDINNOPHARMACEUTICALTECHNOLOGY-CN111606908,2020,ALocationinpatent:Paragraph0508;0517;0565-0567

891843-05-3    1421503-38-9 

[1]CurrentPatentAssignee:PFIZERINC-WO2013/14567,2013,A1Locationinpatent:Page/Pagecolumn54

[2]Jones,Peter;Storer,R.Ian;Sabnis,YogeshA.;Wakenhut,FlorianM.;Whitlock,GavinA.;England,KatherineS.;Mukaiyama,Takasuke;Dehnhardt,ChristophM.;Coe,JothamW.;Kortum,SteveW.;Chrencik,JillE.;Brown,DavidG.;Jones,RhysM.;Murphy,JohnR.;Yeoh,Thean;Morgan,Paul;Kilty,Iain[JournalofMedicinalChemistry,2017,vol.60,#2,p.767-786]

[3]CurrentPatentAssignee:HENANMEDINNOPHARMACEUTICALTECH;HENANMEDINNOPHARMACEUTICALTECHNOLOGY-CN111606908,2020,ALocationinpatent:Paragraph0508;0517;0562-0564

[4]CurrentPatentAssignee:HENANMEDINNOPHARMACEUTICALTECH;HENANMAIYINGNUOPHARMACEUTICALTECH-WO2022/33563,2022,A1Locationinpatent:Page/Pagecolumn26;28-29

[5]Wellaway,ChristopherR.;Baldwin,IanR.;Bamborough,Paul;Barker,Daniel;Bartholomew,MichelleA.;Chung,Chun-Wa;Dümpelfeld,Birgit;Evans,JohnP.;Fazakerley,NealJ.;Homes,Paul;Keeling,StevenP.;Lewell,XiaoQ.;McNab,FinlayW.;Morley,Joanne;Needham,Deborah;Neu,Margarete;VanOosterhout,AntoonJ.M.;Pal,Anshu;Reinhard,FriedrichB.M.;Rianjongdee,Francesco;Robertson,CraigM.;Rowland,Paul;Shah,RishiR.;Sherriff,EmmaB.;Sloan,LisaA.;Teague,Simon;Thomas,DanielA.;Wellaway,Natalie;Wojno-Picon,Justyna;Woolven,JamesM.;Coe,DianeM.[JournalofMedicinalChemistry,2022,vol.65,#1,p.633-664]

1421503-38-9    100-39-0   

1-(benzyloxy)-4-bromo-5-ethyl-2-fluorobenzene 

[1]CurrentPatentAssignee:GOSSAMERBIOSERVICES-WO2022/109492,2022,A1Locationinpatent:Page/Pagecolumn504;505

[2]CurrentPatentAssignee:GOSSAMERBIOSERVICES-WO2022/109492,2022,A1Locationinpatent:Page/Pagecolumn504;505

[3]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-WO2018/165392,2018,A1Locationinpatent:Page/Pagecolumn35;36

[4]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2020/71323,2020,A1Locationinpatent:Paragraph0173-0174

[5]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2021/269437,2021,A1Locationinpatent:Paragraph0218-0219

[6]CurrentPatentAssignee:HENANMEDINNOPHARMACEUTICALTECH;HENANMAIYINGNUOPHARMACEUTICALTECH-WO2022/33563,2022,A1Locationinpatent:Page/Pagecolumn26;28-29

[7]CurrentPatentAssignee:PFIZERINC-US2015/329542,2015,A1Locationinpatent:Paragraph0757

[8]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-WO2017/79205,2017,A1Locationinpatent:Page/Pagecolumn38

1421503-38-9   

C29H40FN3O4SSi 

[1]Ritzén,Andreas;Sørensen,MortenD.;Dack,KevinN.;Greve,DanielR.;Jerre,Anders;Carnerup,MartinA.;Rytved,KlausA.;Bagger-Bahnsen,Jesper[ACSMedicinalChemistryLetters,2016,vol.7,#6,p.641-646]